dr. wakelee on single-agent immunotherapy in nsclc
Published 6 years ago • 204 plays • Length 1:46Download video MP4
Download video MP3
Similar videos
-
1:32
dr. wakelee on immunotherapy versus targeted agents in nsclc
-
2:18
dr. wakelee on first trial to combine antiangiogenesis agents with immunotherapy in nsclc
-
1:35
dr. wakelee on unmet needs for immunotherapy in nsclc
-
2:21
dr. wakelee on the rationale for immunotherapy in nsclc
-
1:54
dr. wakelee on fda approval of frontline pembrolizumab in nsclc
-
1:55
dr. heather wakelee discusses nintedanib plus chemotherapy in nsclc
-
2:15
dr. wakelee on birch trial for atezolizumab in patients with nsclc
-
1:23
dr. wakelee discusses current state of treatment in nsclc
-
1:19
dr. wakelee on combining targeted agents for the treatment of lung cancer
-
1:23
dr. wakelee on veristrat testing in non-small cell lung cancer
-
1:29
dr. wakelee on available treatments following tumor progression in lung cancer
-
1:59
dr. herbst on key immunotherapy findings in nsclc
-
1:21
dr. wakelee on importance of ngs testing in nsclc
-
1:27
dr. wakelee discusses egfr tkis in lung cancer
-
1:13
dr. wakelee discusses the future of lung cancer adjuvant therapy
-
1:57
dr. wakelee on benefits of osimertinib in egfr-mutant nsclc treatment
-
1:40
dr. wakelee on immediate therapy options in lung cancer
-
1:05
dr. wakelee on recent advancements in egfr-mutant nsclc
-
1:10:20
watch drs broderick & wakelee discuss the latest in nsclc: https://bit.ly/2021-nsclc